1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow PEP-3-KLH: new trials by email Literature Review of PEP-3-KLH trials Research Report on PEP-3-KLH
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery PEP-3-KLH conjugate vaccine, daclizumab, temozolomide - Malignant Neoplasms of Brain | Phase 1 | Completed | John Sampson | 16 | 2007-03-01 | 2016-01-21 |
Glioblastoma (1) · Glioma (1) · Gliosarcoma (1)
John Sampson (1)
United States (1)
R21CA132891 (1)